1. A plasma metabolite panel as biomarkers for early primary breast cancer detection. Issue 11 (4th January 2019) Authors: Yuan, Baowen; Schafferer, Simon; Tang, Qiuqiong; Scheffler, Matthias; Nees, Juliane; Heil, Jörg; Schott, Sarah; Golatta, Michael; Wallwiener, Markus; Sohn, Christof; Koal, Therese; Wolf, Barbara; Schneeweiß, Andreas; Burwinkel, Barbara Journal: International journal of cancer Issue: Volume 144:Issue 11(2019) Page Start: 2833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adenomyosis and Myomata: Risks, Problems, and Complications in Diagnosis and Therapy of Adenomyosis and Myomata. (6th August 2018) Authors: De Wilde, Rudy Leon; Wallwiener, Markus; Di Spiezio Sardo, Attilio; Tanos, Vasilios; Becker, Sven Journal: BioMed research international Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Animal Model for Local Pharmacotherapy in Adhesion Prophylaxis—A Proof of Concept. (1st August 2013) Authors: Rajab, Taufiek Konrad; Smaxwil, Luisa; Wallwiener, Markus Journal: Journal of investigative surgery Issue: Volume 26:Number 4(2013:Aug.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation of microRNA expression in matched-paired primary tumor, metastasis and plasma samples of metastatic breast cancer patients. (March 2019) Authors: Deutsch, Thomas; Feisst, Manuel; Nees, Juliane; Stefanovic, Stefan; Hartkopf, Andreas; Taran, Florin-Andrei; Schuetz, Florian; Brucker, Sara; Sohn, Christof; Schneeweiss, Andreas; Burwinkel, Barbara; Wallwiener, Markus Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 234(2019) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany". (February 2021) Authors: Schneeweiss, Andreas; Ettl, Johannes; Lüftner, Diana; Beckmann, Matthias W.; Belleville, Erik; Fasching, Peter A.; Fehm, Tanja N.; Geberth, Matthias; Häberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D.; Hielscher, Carsten; Huober, Jens; Ruckhäberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christia... Journal: Breast Issue: Volume 55(2021) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis. (September 2021) Authors: Hartkopf, Andreas D.; Brucker, Sara Y.; Taran, Florin-Andrei; Harbeck, Nadia; von Au, Alexandra; Naume, Bjørn; Pierga, Jean-Yves; Hoffmann, Oliver; Beckmann, Matthias W.; Rydén, Lisa; Fehm, Tanja; Aft, Rebecca; Solà, Montserrat; Walter, Vincent; Rack, Brigitte; Schuetz, Florian; Borgen, Elin; Ta,... Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017. (August 2021) Authors: Riedel, Fabian; Hoffmann, Ann Sophie; Moderow, Mareike; Feisst, Manuel; Heublein, Sabine; Deutsch, Thomas Maximilian; Schäfgen, Benedikt; Golatta, Michael; Domschke, Christoph; Wallwiener, Markus; Heil, Jörg; Hennigs, André Journal: Breast Issue: Volume 58(2021) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry. (February 2018) Authors: Müller, Volkmar; Nabieva, Naiba; Häberle, Lothar; Taran, Florin-Andrei; Hartkopf, Andreas D.; Volz, Bernhard; Overkamp, Friedrich; Brandl, Anna Lisa; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Ettl, Johannes; Lux, Michael P.; Lüftner, Diana; Belleville, Erik; Fasching, Peter A.; Janni, ... Journal: Breast Issue: Volume 37(2018) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany. (December 2020) Authors: Schneeweiss, Andreas; Ettl, Johannes; Lüftner, Diana; Beckmann, Matthias W.; Belleville, Erik; Fasching, Peter A.; Fehm, Tanja N.; Geberth, Matthias; Häberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D.; Hielscher, Carsten; Huober, Jens; Ruckhäberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christia... Journal: Breast Issue: Volume 54(2020) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients. (2nd January 2016) Authors: Fremd, Carlo; Stefanovic, Stefan; Beckhove, Philipp; Pritsch, Maria; Lim, Hendry; Wallwiener, Markus; Heil, Joerg; Golatta, Michael; Rom, Joachim; Sohn, Christof; Schneeweiss, Andreas; Schuetz, Florian; Domschke, Christoph Journal: Oncoimmunology Issue: Volume 5:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗